Claire Rychlewski

3 days ago | axios.com | Claire Rychlewski

Axios Pro Exclusive ContentIllustration: Aïda Amer/AxiosMedical AI scribe Abridge has raised $300 million, valuing it at $5.3 billion, per the Wall Street Journal. Why it matters: It's nearly double the company's February valuation, demonstrating investor confidence that Abridge can expand beyond scribing. Between the lines: Scribing has become increasingly commodified, and billing management is the low-hanging fruit that can help players like Abridge diversify.

1 week ago | axios.com | Claire Rychlewski

Axios Pro Exclusive ContentIllustration: Aïda Amer/AxiosAmulet Capital is exploring a sale of SSI Strategy, a biotech consulting firm, four sources familiar with the situation tell Axios Pro. Why it matters: This would be at least the fourth pharma services deal since last October. The latest: The Parsippany, New Jersey-based company, which is generating about $25 million in EBITDA, has collected indications of interest and is in the second round.

1 week ago | axios.com | Claire Rychlewski

Vestar Capital has hired Evercore to sell provider management software company Quest Analytics, two sources familiar with the situation tell Axios Pro. Why it matters: There's no shortage of potential buyers for Quest, which has lucrative contracts with the government and major insurers. Inside the room: Quest is generating about $35 million in EBITDA, the sources say. "That's a pure SaaS business that's going to trade very well," one source says.

1 week ago | axios.com | Claire Rychlewski

Ambulatory infusion provider Local Infusion raised a $30 million Series B led by Transformation Capital, CEO Woody Baum tells Axios exclusively. Why it matters: The company chose venture capital when private equity is beating down infusion doors. What they're saying: "We're going to be one of the five or six largest companies in the industry by the end of the year, and probably top three by the end of next year," Baum says.

2 weeks ago | axios.com | Claire Rychlewski

Hungry, a workplace food catering company, is valued at $325 million after acquiring corporate wellness tech startup Garten, CEO Jeff Grass tells Axios Pro exclusively. Why it matters: Hungry expects to pursue more buys and could raise more capital to finance the strategy, Grass says. Catch up quick: The deal, a mix of cash and stock, has yet to be formally announced but closed last August.